The IDEA-FAST 2023 General Assembly will take part over two days in Barcelona, during which the consortium will tackle accelerating the implementation of the on-going Clinical Observation Study, data analysis, patient engagement and sustainability strategy through plenary and breakout sessions.
Start:
End:
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 853981. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA and PARKINSON’S DISEASE SOCIETY OF THE UNITED KINGDOM LBG.
